Jimmy works with a variety of clients including small to mid-size biotechnology companies and technology transfer offices. He has been involved in developing a start-up client’s patent portfolio from scratch, including defining areas where patents could be filed and carrying out landscape searches. Jimmy additionally has experience in analysis of third party patents and portfolios, including surveillance projects and freedom to operate searches. He has also been involved in due diligence carried out on a client’s patent portfolio.
Jimmy drafts and prosecutes patent applications relating to a diverse range of inventions in the biotechnology and life sciences fields, notably immunology and transgenic animals. He has also been involved in oppositions and appeals before the European Patent Office relating, for example, to therapeutic antibody targets, and in a multinational opposition/litigation project relating to transgenic animal platforms for antibody drug discovery.
Jimmy joined J A Kemp in 2006 and became a partner in 2016. He is a French national and speaks fluent French.
University of Oxford, Masters Degree in Biochemistry; Cancer Research UK and University College London, PhD in Molecular Biology
European Patent Attorney, UK Chartered Patent Attorney
Fellow of the Chartered Institute of Patent Attorneys (CIPA), Member of the Institute of Professional Representatives before the European Patent Office (EPI)